{
    "clinical_study": {
        "@rank": "144441", 
        "arm_group": [
            {
                "arm_group_label": "Islet transplant recipients", 
                "arm_group_type": "Experimental", 
                "description": "Hypoglycemic and euglycemic glucose clamp"
            }, 
            {
                "arm_group_label": "Type 1 diabetic subjects", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Hypoglycemic and  euglycemic glucose clamp."
            }, 
            {
                "arm_group_label": "Non-diabetic subjects", 
                "arm_group_type": "Active Comparator", 
                "description": "Hypoglycemic and  euglycemic glucose clamp"
            }
        ], 
        "brief_summary": {
            "textblock": "Pancreatic islet transplantation improves glucose counterregulation and stabilizes glycemic\n      control in patients with type 1 diabetes mellitus prone to severe hypoglycemia even if\n      insulin independence is not achieved. However, the extent and underlying metabolic pathways\n      of this improvement are unknown. Investigators therefore compare systemic glucose turnover\n      including lactate gluconeogenesis and muscle glucose utilization, between insulin-requiring\n      islet transplant recipients, matched type 1 diabetic subjects who did not receive islet\n      transplantation, and matched healthy non-diabetic subjects."
        }, 
        "brief_title": "Mechanisms of Glucose Counterregulation in Pancreatic Islet Transplantation", 
        "completion_date": {
            "#text": "November 2011", 
            "@type": "Actual"
        }, 
        "condition": "Type 1 Diabetes Mellitus", 
        "condition_browse": {
            "mesh_term": [
                "Diabetes Mellitus", 
                "Diabetes Mellitus, Type 1"
            ]
        }, 
        "detailed_description": {
            "textblock": "Subjects (n=12 each group) undergo a hypoglycemic and a euglycemic   hyperinsulinemic clamp\n      in a randomized fashion. Systemic and skeletal muscle glucose and lactate kinetics are\n      assessed using a combination of isotopic and forearm balance techniques."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "T1DM/ITX+\n\n        Inclusion Criteria:\n\n          -  Type 1 Diabetes\n\n          -  Pancreatic islet transplantation\n\n        Exclusion Criteria:\n\n          -  Type 2 Diabetes"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "36", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "August 13, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01668485", 
            "org_study_id": "T1DM/ITX"
        }, 
        "intervention": {
            "arm_group_label": [
                "Islet transplant recipients", 
                "Type 1 diabetic subjects", 
                "Non-diabetic subjects"
            ], 
            "description": "Each study participant will be subjected to a continuous infusion of insulin at a rate of 0.8 mU\u00b7kg\u22121\u00b7min\u22121 to induce hypoglycemia (blood glucose 2.8-3 mmol/l) for 30 minutes. At least two weeks later an identical insulin infusion will be administered and euglycemia (blood glucose 5 mmol/l) will be targeted. The order of these interventions will be subject to randomization.", 
            "intervention_name": "Hypoglycemic and euglycemic glucose clamp", 
            "intervention_type": "Procedure"
        }, 
        "intervention_browse": {
            "mesh_term": "Hypoglycemic Agents"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Type 1 diabetes mellitus", 
            "hypoglycemia counterregulation,", 
            "pancreatic islet transplantation"
        ], 
        "lastchanged_date": "August 17, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "Giessen", 
                    "country": "Germany", 
                    "state": "Hessia", 
                    "zip": "35392"
                }, 
                "name": "Justus Liebig University"
            }
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_arms": "3", 
        "official_title": "Metabolic Studies in Type 1 Diabetic Patients After Allogenic Intraportal Islet Transplantation.", 
        "overall_official": {
            "affiliation": "Justus Liebig University", 
            "last_name": "Thomas Linn, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Germany: Federal Institute for Drugs and Medical Devices", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "November 2010", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Whole body glucose counterregulation is the difference in glucose infusion rates required to maintain the glycemic goal between the hypoglycemic and euglycemic clamp. Clamps were performed at two time points at least two weeks apart. Participants will be followed for the duration of 6-8 weeks to perform the hypoglycemic and euglycemic clamp tests.", 
            "measure": "Whole body glucose counterregulation", 
            "safety_issue": "No", 
            "time_frame": "6-8 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01668485"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Giessen", 
            "investigator_full_name": "Thomas Linn", 
            "investigator_title": "Professor Dr. med.", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Systemic glucose release is the amount of glucose released primarily from the liver into the blood compartment during a given time. The unit of measure is \u03bcmol/kg/min.\nParticipants will be followed for the duration of 6-8 weeks to perform the hypoglycemic and euglycemic clamp tests that will yield this parameter.", 
                "measure": "Systemic glucose release", 
                "safety_issue": "No", 
                "time_frame": "6-8 weeks"
            }, 
            {
                "description": "Participants will be followed for the duration of 6-8 weeks to perform the euglycemic and hypoglycemic clamp tests. The unit of measure of this parameters is \u03bcmol/kg/min.", 
                "measure": "Skeletal muscle glucose disposal", 
                "safety_issue": "No", 
                "time_frame": "6-8 weeks"
            }, 
            {
                "description": "This parameter is determined by labelled lactate infused into the proband. The rate of the de novo synthesis of glucose (gluconeogenesis) is determined by the degree of incorporation of the lactate label into glucose molecules. The unit of measure of this parameter is \u03bcmol/kg/min.", 
                "measure": "Gluconeogenesis from lactate", 
                "safety_issue": "No", 
                "time_frame": "6-8 weeks"
            }
        ], 
        "source": "University of Giessen", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Giessen", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2001", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Bio-equivalence Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "August 2012"
    }
}